Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,998,266
New position
Shares Held
1,200,587
first reported quarter
Ownership
2.70%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BRAIDWELL LP holds $138,308,361 across 5 Drug Manufacturers - Specialty & Generic names. BIOA ranks #2 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
652,121 | $85,910,420 | |
| 2 | BIOA |
BioAge Labs, Inc.
This page
|
1,200,587 | $20,998,266 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
272,522 | $13,121,934 | |
| 4 | EOLS |
Evolus, Inc.
|
3,105,209 | $12,762,408 | |
| 5 | HROW |
Harrow, Inc.
|
156,419 | $5,515,333 |
All Filings in BIOA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,998,266 | 1,200,587 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||